Transcriptional responses in the rat nasal epithelium following subchronic inhalation of naphthalene vapor

Toxicology and Applied Pharmacology

Volumn 280, Issue 1, 2014, Pages 78-85

  Clewell, H J ^a   Efremenko, A ^a   Campbell, J L ^a   Dodd, D E ^a   Thomas, R S ^a,b  

^a HAMNER INSTITUTES FOR HEALTH SCIENCES   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Genomics; Inhalation; Naphthalene; Risk assessment

Indexed keywords

GLUTATHIONE; NAPHTHALENE; RNA; NAPHTHALENE DERIVATIVE;

ADENOMA; ANIMAL EXPERIMENT; ARTICLE; BIOASSAY; CARCINOGENICITY; CELL CYCLE; CELL CYCLE REGULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; DNA DAMAGE; DOSIMETRY; DOWN REGULATION; EXPOSURE; FEMALE; GENE EXPRESSION; GLUTATHIONE METABOLISM; HOMEOSTASIS; INCIDENCE; INFLAMMATION; INHALATION; MALE; MICROARRAY ANALYSIS; NEUROBLASTOMA; NONHUMAN; NOSE CAVITY; NTP BIOASSAY; OLFACTORY EPITHELIUM; OXIDATIVE STRESS; RAT; RESPIRATORY EPITHELIUM; RISK ASSESSMENT; RNA ISOLATION; SEX DIFFERENCE; TARGET ORGAN; UPREGULATION; VAPOR; ANIMAL TISSUE; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); FISCHER 344 RAT; PROTEIN HOMEOSTASIS; SIGNAL TRANSDUCTION; TOXICITY TESTING; ADVERSE EFFECTS; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; GENETIC TRANSCRIPTION; INHALATIONAL DRUG ADMINISTRATION; NOSE MUCOSA; PATHOLOGY; PHYSIOLOGY;

ADMINISTRATION, INHALATION; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INHALATION EXPOSURE; MALE; NAPHTHALENES; NASAL MUCOSA; RATS; RATS, INBRED F344; TRANSCRIPTION, GENETIC;

EID: 84906486575     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2014.06.015     Document Type: Article

References (23)

1. Abdo K.M., Eustis S.L., McDonald M., Jokinen M.P., Adkins B., Haseman J.K. Naphthalene: a respiratory tract toxicant and carcinogen for mice. Inhal. Toxicol. 1992, 4(4):393-409.
2. Abdo K.M., Grumbein S., Chou B.J., Herbert R. Toxicity and carcinogenicity study in F344 rats following 2years of whole-body exposure to naphthalene vapors. Inhal. Toxicol. 2001, 13:931-950.
3. Akaike H. Information theory and an extension of the maximum likelihood principle. 2nd International symposium on information theory 1973, 1973:267-281.
4. Baldwin R.M., Shultz M.A., Buckpitt A.R. Bioactivation of the pulmonary toxicants naphthalene and 1-nitronaphthalene by rat CYP2F4. J. Pharmacol. Exp. Ther. 2005, 312:857-865.
5. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 1995, 57:289-300.
6. Bogen K.T., Benson J.M., Yost G.S., Morris J.B., Dahl A.R., Clewell H.J., Krishnan K., Omiecinski C.J. Naphthalene metabolism in relation to target tissue anatomy, physiology, cytotoxicity and tumorigenic mechanism of action. Regul. Toxicol. Pharmacol. 2008, 51(2 Suppl.):S27-S36.
7. Campbell J.L., Andersen M.E., Clewell H.J. A hybrid CFD-PBPK model for naphthalene in rat and human with IVIVE for nasal tissue metabolism and cross-species dosimetry. Inhal. Toxicol. 2014, 26(6):333-344.
8. Cruzan G., Bus J., Banton M., Gingell R., Carlson G. Mouse specific lung tumors from CYP2F2-mediated cytotoxic metabolism: an endpoint/toxic response where data from multiple chemicals converge to support a mode of action. Regul. Toxicol. Pharmacol. 2009, 55:205-218.
9. Dodd D.E., Gross E.A., Miller R.A., Wong B.A. Nasal olfactory epithelial lesions in F344 and SD rats following 1- and 5-day inhalation exposure to naphthalene vapor. Int. J. Toxicol. 2010, 29:175-184.
10. Dodd D.E., Wong B.A., Gross E.A., Miller R.A. Nasal epithelial lesions in F344 rats following a 90-day inhalation exposure to naphthalene. Inhal. Toxicol. 2012, 24(1):70-79.
11. Irizarry R.A., Bolstad B.M., Collin F., Cope L.M., Hobbs B., Speed T.P. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003, 31:e15.
12. Long P.H., Herbert R.A., Peckham J.C., Grumbein S.L., Shackelford C.C., Abdo K. Morphology of nasal lesions in F344/N rats following chronic inhalation exposure to naphthalene vapors. Toxicol. Pathol. 2003, 31(6):655-664.
13. National Toxicology Program (NTP) Toxicology and carcinogenesis studies of naphthalene in B6C3F1 mice (inhalation studies). Technical Report Series No 410. NTP 1992, Research Triangle Park, NC.
14. National Toxicology Program (NTP) Toxicology and carcinogenesis studies of naphthalene in F344/N rats 2000, U.S. Department of Health and Human Services National Toxicology Program, Washington, D.C.
15. Odum J., Foster J.R., Green T. A mechanism for the development of Clara cell lesions in the mouse lung after exposure to trichloroethylene. Chem. Biol. Interact. 1992, 83(2):135-153.
16. Posada D., Buckley T.R. Model selection and model averaging in phylogenetics: advantages of akaike information criterion and bayesian approaches over likelihood ratio tests. Syst. Biol. 2004, 53:793-808.
17. Preston R.J. DNA reactivity as a mode of action and its relevance to cancer risk assessment. Toxicol. Pathol. 2013, 41(2):322-325.
18. Thomas R.S., Allen B.C., Nong A., Yang L., Bermudez E., Clewell H.J., Andersen M.E. A method to integrate benchmark dose estimates with genomic data to assess the functional effects of chemical exposure. Toxicol. Sci. 2007, 98:240-248.
19. Thomas R.S., Philbert M.A., Auerbach S.S., Wetmore B.A., Devito M.J., Cote I., Rowlands J.C., Whelan M.P., Hays S.M., Andersen M.E., Meek M.E., Reiter L.W., Lambert J.C., Clewell H.J., Stephens M.L., Zhao Q.J., Wesselkamper S.C., Flowers L., Carney E.W., Pastoor T.P., Petersen D.D., Yauk C.L., Nong A. Incorporating new technologies into toxicity testing and risk assessment: moving from 21st century vision to a data-driven framework. Toxicol. Sci. 2013, 136(1):4-18.
20. Thomas R.S., Wesselkamper S.C., Wang N.C., Zhao Q.J., Petersen D.D., Lambert J.C., Cote I., Yang L., Healy E., Black M.B., Clewell H.J., Allen B.C., Andersen M.E. Temporal concordance between apical and transcriptional points-of-departure for chemical risk assessment. Toxicol. Sci. 2013, 134(1):180-194.
21. United States Environmental Protection Agency (USEPA) Methods for derivation of inhalation reference concentrations and application of inhalation dosimetry 1994, (EPA/600/8-90/066F).
22. United States Environmental Protection Agency (USEPA) Guidelines for carcinogen risk assessment 2005, (EPA/630/P-03/001F).
23. Yang L., Allen B.C., Thomas R.S. BMDExpress: a software tool for the benchmark dose analyses of genomic data. BMC Genomics 2007, 8:387.